Patient previous medications and the amendments made
| Drug | Referred patients taking medication (%) | Medication stopped (%) | Medication initiated and titrated (%) | Medication dosage altered (%) |
|---|---|---|---|---|
| Statins use was not recorded in the earlier phase of the service. | ||||
| *Intolerance, significant renal impairment, side effects; †includes patients with valvar dysfunction, hypertensive heart disease, diabetes; ‡side effects particularly bronchospasm or significant peripheral arterial disease; §includes patients with angina, heart failure, atrial fibrillation (rate control, rhythm maintenance), hypertension; ¶loop and thiazide diuretics, for hart failure and hypertension; **loop diuretic changed to thiazide or vice versa or dosage of diuretic reduced or increased. | ||||
| ACE, angiotensin converting enzyme; CCA, calcium channel antagonists. | ||||
| ACE inhibitors | 21 | 2.1* | 16.5† | 7.4 |
| β Blocker | 9.9 | 0.3‡ | 15.1§ | 3.6 |
| Aspirin | 18.9 | – | 32 | 2.9 |
| Diuretics¶ | 57.1 | 3.7 | 4.3 | 13.5** |
| Digoxin | 9.7 | 0.6 | 1.7 | 4.3 |
| CCA | 15.2 | 0.2 | 4.7 | 3.3 |
| Warfarin | 1.2 | – | 5.4 | – |
| Nitrates | 23.4 | 1.3 | 3.3 | 7.2 |
| Bronchodilators | 13 | – | 4.3 | – |